Sanofi-Aventis U.S. LLC v. Food & Drug Administration

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• finding it unlikely that the plaintiff had \met this Circuit’s stringent standard for irreparable harm\ where the plaintiff stood to lose approximately $2.5 billion in annual domestic sales because the plaintiff had worldwide revenues of $40 billion annually

Source: CourtListener parenthetical corpus (CC0).